Generali

Model update: NatCat hits Generali

29/11/23 -"We have cut our Generali Target Price due to the weaker H2 which was impacted by higher NatCat losses than had been forecast in our previous model. Despite maintaining a cautious outlook, we ..."

PDF page sample
Pages
57
Language
English
Published on
29/11/23
Download
You may also be interested by these reports :
04/10/24
Uniqa has announced the completion of the sale of its Russian subsidiary Raiffeisen Life. The group no longer has any activity in Russia. Raiffeisen ...
19/09/24
• Gross premiums were up by 5% to €1.94bn for H1 24 compared to H1 23 • Pre-tax loss of €64m for H2 24 in p&c business compared to €16m for H1 23 • ...
12/09/24
• Insurance revenues were up by 1% to CHF2.7bn for H1 24 • Net income attributable to shareholders increased by 6% to CHF220m for H1 24 versus H1 23 ...
05/09/24
M&G’s H1 24 results were down yoy, but slightly above consensus. The company suffered from net outflows and decided to combine its Life and Wealth ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO